Tracking VERA? Get live short interest, options flow, and signals on ORTEX.Sign up free →

Vera Therapeutics, Inc. (VERA) short interest & options flow

NASDAQ

Vera Therapeutics has passed its Q2 earnings test and the result was ugly — the stock fell nearly 8% on August 10 following the print, and another 4% the day after, leaving it at $30.29 and down 28% over the past month. The options market called it right. Heading into the print, the put/call ratio had jumped from a steady 0.35 through July to 0.63 — nearly 1.8 standard deviations…

$28.92+3.73% 1d+4.33% 1w-14.94% 1mClose: 19 Oct 2026

Short interest % of float: High
Cost to borrow: Low
Availability: High
Put / call ratio

Market cap: $2.09B
Next earnings: 5 Nov 2026

See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 20 Oct 2026

VERA news and analysis

RSS

No long-form analysis yet for VERA. Pulse alerts and the live data picture are available on ORTEX.

Open VERA on ORTEX →

Want the live picture for VERA?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for VERA — free to start on ORTEX.